Funds and ETFs Laboratory Corporation of America Holdings

Equities

LH

US50540R4092

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 10:29:38 2024-05-10 am EDT 5-day change 1st Jan Change
207.1 USD +0.47% Intraday chart for Laboratory Corporation of America Holdings +2.83% -8.92%

ETFs positioned on Laboratory Corporation of America Holdings

Name Weight AuM 1st Jan change Investor Rating
0.01% 0 M€ +0.53% -
0.01% 0 M€ +4.12% -
0.24% 0 M€ +8.37% -
1.85% 0 M€ +6.50% -
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
206.2 USD
Average target price
239.6 USD
Spread / Average Target
+16.23%
Consensus
  1. Stock Market
  2. Equities
  3. LH Stock
  4. Funds and ETFs Laboratory Corporation of America Holdings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW